Form 10-K

The report describes Teva's 2021 global pharmaceutical operations and consolidated revenues of $15,878 million. It reports a workforce of 37,537 employees and discusses inclusion, diversity, health and safety, training, and employee engagement programs. Environmentally, the company continued implementing a global EHS management system across all countries where it operates and reported progress on its ESG strategy. The report also notes that a separate 2021 ESG Progress report was expected to provide enhanced ESG disclosures.

Report type

Annual Report

Class

Financial

Scope

Full report

Fiscal year

2021

Period

1 January 2021 – 31 December 2021

Publication date

9 February 2022

Language

English

Pages

 

File size